PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly Depreciation & Amortization (CF) of $1.7 million for Q1 2026, up 17.63% year-over-year from $1.5 million in Q1 2025, and up 1.52% quarter-over-quarter from $1.7 million in Q4 2025.
PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 17.63% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.6 million (up 20.36% YoY), while the FY2025 annual figure was $6.4 million, up 22.09% from the prior year.
- Depreciation & Amortization (CF) grew to $1.7 million in Q1 2026 per PRCT's latest filing, from $1.7 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q1 2026 and bottomed at $642000.0 in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $1.2 million across 5 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) fell 17.16% — and 2023, when it soared 98.79%.
- PROCEPT BioRobotics' Depreciation & Amortization (CF) stood at $663000.0 in 2022, then jumped by 98.79% to $1.3 million in 2023, then advanced by 10.24% to $1.5 million in 2024, then rose by 17.62% to $1.7 million in 2025, then advanced by 1.52% to $1.7 million in 2026.
- Business Quant data shows PRCT's Depreciation & Amortization (CF) at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | PROCEPT BioRobotics | 1.19 Bn | 911.91 Mn | 62.38 Mn | 1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.99 Mn |
| Jun 30, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |